Welcome to Miltenyi Biotec and BioInnovation Institute networking and seminar session on Stem Cell Therapy Insights on May 31 2022.
We have invited Agnete Kirkeby, Associate Professor from Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW and Principal Investigator at Lund Stem Cell Center, to present her work on using iPSC cells for the treatment of Parkinsons disease. Meet the renowned entrepreneur, David Hay, Professor at the University of Edinburgh and founder and CEO of Stimuliver, who will inspire with his journey behind launching the start-up that is poised to challenge the status quo of liver transplantation. Last but not least, we welcome Jakob Lerche Hansen, Chief Scientific Officer at Blue Cell Therapeutics, who will present their exciting progress on the use of adipose derived stem cells in order to treat chronic disease.
Read more and sign up
Agenda:
| 16.00 | Markus Herrgård, Chief Technology Officer, BioInnovation Institute Welcome and introduction |
| 16.05 | Agnete Kirkeby, Associate Professor, Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW/Principal Investigator, Lund University, Lund Stem Cell Center Bringing a stem cell therapy to the clinic for treatment of Parkinsons disease |
| 16.30 | David Hay, Professor of Tissue Engineering, University of Edinburgh/Founder and CEO, Stimuliver Building implantable liver tissue from pluripotent stem cells |
| 16.55 | Jakob Lerche Hansen, Chief Scientific Officer, Blue Cell Therapeutics Cell therapy to cure erectile dysfunction |
| 17.10 | Q&A roundtable discussion |
| 17.30 | Drinks, refreshments etc. |
Organised by:
 |  |